Back

Independent serum metabolomics approaches identify disrupted glutamic acid and serine metabolism in Parkinson's disease patients

Gervasoni, J.; Marino, C.; Imarisio, A.; Santucci, L.; Napolitano, E.; Nuzzo, T.; Yahyavi, I.; Avenali, M.; Cicchinelli, M.; Buongarzone, G.; Galandra, C.; Picascia, M.; Grimaldi, M.; Pacchetti, C.; Errico, F.; D'Ursi, A. M.; Urbani, A.; Valente, E. M.; Usiello, A.

2025-06-13 neurology
10.1101/2025.06.12.25329524 medRxiv
Show abstract

Previous studies assessing blood metabolomic profiles in Parkinsons disease (PD) patients showed inconsistent results. Here, we employed {superscript 1}H-NMR and UPLC/MS analyses on serum samples from a cohort of PD patients and healthy controls (HC). Compared to HC, PD patients showed: (i) higher glutamine, serine, pyruvate and lower -ketoglutarate levels (1H-NMR); (ii) higher glycine and lower glutamic acid concentrations (UPLC/MS). Several pathways associated with amino acids, mitochondrial and antioxidant metabolism emerged as dysregulated in PD. Our findings highlight a prominent disruption of cellular bioenergetic pathways and amino acid homeostasis in PD.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.